VHE: Corporate Governance Report (first 06 months)
VHE: Result of transaction of Directors, PDMR (Nguyen The Hung)
VHE: Explanation on difference in profit after tax in Q2.2021
With risks from interruption of the medical ingredient supply chain and losses in the hospital channel, the Vietnamese pharma industry experienced a topsy-turvy first half of 2021, with potential growth set to focus on mergers and acquisitions.